Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Acquired by Natixis Advisors LLC

Natixis Advisors LLC raised its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 7.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,435 shares of the medical instruments supplier's stock after purchasing an additional 4,891 shares during the quarter. Natixis Advisors LLC owned about 0.12% of Merit Medical Systems worth $7,006,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Pathstone Holdings LLC grew its position in shares of Merit Medical Systems by 20.1% in the third quarter. Pathstone Holdings LLC now owns 34,950 shares of the medical instruments supplier's stock valued at $3,454,000 after purchasing an additional 5,844 shares during the period. Jennison Associates LLC acquired a new position in shares of Merit Medical Systems in the 3rd quarter valued at $935,000. Connor Clark & Lunn Investment Management Ltd. boosted its stake in Merit Medical Systems by 216.8% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 10,064 shares of the medical instruments supplier's stock worth $995,000 after buying an additional 6,887 shares during the period. King Luther Capital Management Corp acquired a new stake in Merit Medical Systems in the 3rd quarter valued at approximately $5,462,000. Finally, Intech Investment Management LLC raised its holdings in shares of Merit Medical Systems by 67.6% in the 3rd quarter. Intech Investment Management LLC now owns 14,024 shares of the medical instruments supplier's stock valued at $1,386,000 after buying an additional 5,654 shares during the period. 99.66% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Insider Transactions at Merit Medical Systems

In other Merit Medical Systems news, insider Brian G. Lloyd sold 25,000 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the transaction, the insider now owns 38,993 shares of the company's stock, valued at $3,879,803.50. This represents a 39.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Raul Jr. Parra sold 5,361 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $103.58, for a total value of $555,292.38. Following the transaction, the chief financial officer now owns 24,201 shares in the company, valued at $2,506,739.58. This trade represents a 18.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 109,132 shares of company stock worth $11,139,521 over the last ninety days. 3.70% of the stock is currently owned by corporate insiders.

Merit Medical Systems Price Performance

Shares of MMSI traded up $0.06 during trading hours on Tuesday, reaching $104.74. 548,986 shares of the company traded hands, compared to its average volume of 424,516. The stock has a market capitalization of $6.16 billion, a PE ratio of 51.34, a price-to-earnings-growth ratio of 2.34 and a beta of 0.91. The stock has a fifty day simple moving average of $104.11 and a 200 day simple moving average of $100.87. Merit Medical Systems, Inc. has a fifty-two week low of $70.70 and a fifty-two week high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Analyst Ratings Changes

MMSI has been the topic of a number of analyst reports. Canaccord Genuity Group reduced their price target on Merit Medical Systems from $128.00 to $127.00 and set a "buy" rating on the stock in a research report on Wednesday, February 26th. Barrington Research reduced their target price on shares of Merit Medical Systems from $115.00 to $111.00 and set an "outperform" rating on the stock in a report on Wednesday, February 26th. Raymond James boosted their price target on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Tuesday, December 31st. Piper Sandler reaffirmed an "overweight" rating and set a $116.00 price objective (up from $114.00) on shares of Merit Medical Systems in a research report on Wednesday, January 29th. Finally, Wells Fargo & Company lowered their target price on shares of Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a research note on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $110.78.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.